pI: 6.9001 |
Length (AA): 461 |
MW (Da): 52300 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_127918)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G26730 | RING/U-box domain-containing protein |
Babesia bovis | BBOV_IV009010 | hypothetical protein |
Candida albicans | CaO19.5676 | similar to S. cerevisiae YLR427W |
Candida albicans | CaO19.13121 | similar to S. cerevisiae YLR427W |
Cryptosporidium hominis | Chro.20190 | CG12099-PB |
Cryptosporidium parvum | cgd2_1750 | ring domain |
Dictyostelium discoideum | DDB_G0269996 | RING zinc finger-containing protein |
Drosophila melanogaster | Dmel_CG12099 | CG12099 gene product from transcript CG12099-RA |
Echinococcus granulosus | EgrG_002015400 | zf-C3HC4_2 and Pfam-B_7383 and Pfam-B_16880 and Pfam-B_12017 and Pfam-B_10913 and Pfam-B_2478 and Pfam-B_3518 and Pfam-B_6278 do |
Echinococcus granulosus | EgrG_000739500 | RING finger protein 10 |
Echinococcus granulosus | EgrG_000739600 | RING finger protein 10 |
Entamoeba histolytica | EHI_052080 | hypothetical protein |
Echinococcus multilocularis | EmuJ_000739500 | RING finger protein 10 |
Echinococcus multilocularis | EmuJ_000739600 | RING finger protein 10 |
Homo sapiens | ENSG00000022840 | ring finger protein 10 |
Leishmania braziliensis | LbrM.21.2090 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_081130.1 | Zinc finger, C3HC4 type (RING finger), putative |
Leishmania infantum | LinJ.08.1130 | hypothetical protein, conserved |
Leishmania major | LmjF.08.1240 | hypothetical protein, conserved |
Leishmania major | LmjF.08.1215 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.08.1215 | hypothetical protein, conserved |
Mus musculus | ENSMUSG00000041740 | ring finger protein 10 |
Neospora caninum | NCLIV_050710 | zinc finger (C3HC4 RING finger) protein, putative |
Oryza sativa | 4329478 | Os02g0516600 |
Plasmodium berghei | PBANKA_1210400 | E3 ubiquitin-protein ligase, putative |
Plasmodium falciparum | PF3D7_1012000 | E3 ubiquitin-protein ligase, putative |
Plasmodium knowlesi | PKNH_0811800 | E3 ubiquitin-protein ligase, putative |
Plasmodium vivax | PVX_094820 | hypothetical protein, conserved |
Plasmodium yoelii | PY03640 | Drosophila melanogaster LD09551p |
Saccharomyces cerevisiae | YLR427W | Mag2p |
Schistosoma japonicum | Sjp_0020530 | RING finger protein 10, putative |
Schistosoma mansoni | Smp_038700.1 | hypothetical protein |
Schistosoma mansoni | Smp_038700.7 | hypothetical protein |
Schistosoma mansoni | Smp_038700.6 | hypothetical protein |
Schmidtea mediterranea | mk4.006188.00 | |
Trypanosoma brucei gambiense | Tbg972.5.4290 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.5.3070 | Zinc finger, C3HC4 type (RING finger), putative |
Trypanosoma congolense | TcIL3000_5_3400 | Zinc finger, C3HC4 type (RING finger) containing protein, putative |
Trypanosoma cruzi | TcCLB.510173.110 | Zinc finger, C3HC4 type (RING finger), putative |
Trypanosoma cruzi | TcCLB.509721.79 | Zinc finger, C3HC4 type (RING finger), putative |
Toxoplasma gondii | TGME49_236780 | zinc finger, C3HC4 type (RING finger) domain-containing protein |
Trichomonas vaginalis | TVAG_082580 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_038490 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_257890 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.5.3070 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.5.3070 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.5.3070 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.5.3070 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_1210400 | Plasmodium berghei | Dispensable | plasmo |
TGME49_236780 | Toxoplasma gondii | Essentiality uncertain | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.